FAQ's from Dr. Richard Wagner, Chair of the Association for Cancer Research in Stuttgart, Germany
Excerpts from: ISCADOR: Mistletoe and Cancer Therapy
Book published by Lantern Books, New York, NY
Printed with kind permission of Christine Murphy, Editor
Q. Which types of tumors react well to Iscador®?
A. Studies show a significant increase in patient survival time with treatment of Iscador® in various stages of cervical, ovarian, vaginal, mammary, stomach, bronchial, and other carcinomas, all of which indicate the efficacy of Iscador® treatment.
Q. Can Iscador® be administered at the same time as chemotherapy?
A. Treatment with Iscador® can and should be administered during chemotherapy, since the latter causes a decrease in the white blood cell count. Generally, tolerance to chemotherapy is improved by simultaneous treatment with Iscador®.
Q. Can therapy with Iscador® be combined with chemotherapy, hormone therapy or radiation?
A. In my opinion, Iscador® therapy should always be carried out in conjunction with chemotherapy, radiation, or other conventional cancer treatments. During chemotherapy, the immune competence of the organism is radically reduced. Administering Iscador® can provide a positive, balancing effect, which will stabilize the leucocytes. This means that chemotherapy, if necessary, can be carried out with success, and without doing greater damage to the immune system than necessary. Therapy with Iscador® can often prevent the interruption of chemotherapy due to leukopenia.
Q. What methods of alternative therapy can be used in conjunction with Iscador®?
A. So-called alternative treatments are manifold, ranging from treatment with enzyme preparations, vitamin preparations and trace elements, to ozone therapy, various kinds of blood cleansings and many alleged immune-stimulating methods. It is important to know that mistletoe therapy is not an alternative therapy, but is included within the framework of an anthroposophically extended therapy.